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Stroke-unit care for acute stroke patients: an observational 
follow-up study
Livia Candelise, Monica Gattinoni, Anna Bersano, Giuseppe Micieli, Roberto Sterzi, Alberto Morabito, on the behalf of the PROSIT Study Group
Summary
Background Large numbers of stroke patients arrive at hospital at a very early stage, and eﬀ ective treatments for the 
acute phase of the disease are available. However, evidence that patients with acute stroke beneﬁ t from stroke-unit 
care is scarce. Our aim was to determine whether admission to a stroke unit, rather than a conventional ward, aﬀ ected 
the outcome of patients with acute stroke. 
Methods We did an observational follow-up study of 11 572 acute stroke patients hospitalised within 48 h of the onset 
of symptoms either in a stroke unit (n=4936) or in a conventional ward (6636). Patients were identiﬁ ed retrospectively 
from discharge records from 260 Italian hospitals. The primary outcome was mortality or disability (Rankin score 
greater than two), assessed prospectively by independent, masked assessors 2 years after admission. Analyses were 
adjusted for patient characteristics and clustered at the hospital level. 
Findings Overall, 1576 patients died in hospital; 2169 died during the follow-up period. 347 patients were lost to 
follow-up. Compared with conventional-ward care, stroke-unit care was associated with a reduced probability of death 
or being disabled at the end of follow-up (odds ratio 0·81, 95% CI 0·72–0·91; p=0·0001). The potential beneﬁ t was 
signiﬁ cant across all age ranges and clinical characteristics, except for unconsciousness. No speciﬁ c elements of 
setting, organisation, or process of care were associated with outcome. 
Interpretation Admission to a stroke-unit ward with dedicated beds and staﬀ  within 48 h of onset should be 
recommended for all patients with acute stroke. 
Introduction
Several randomised controlled trials have been done in 
diﬀ erent countries and environments to assess the eﬀ ective-
ness of stroke-unit care for hospitalised stroke patients.1 
The results of these studies were combined in a Cochrane 
systematic review, which deﬁ nitively showed the beneﬁ t of 
stroke-unit care.1 However, there is still some delay in 
implementation of stroke-unit wards in European countries.2 
The large-scale applicability of some of the complex 
interventions that were used experimentally on small, 
selected groups of patients included in the randomised 
trials is debatable. Guidelines diﬀ er about important aspects 
of stroke care—eg, acuteness for admission, patient 
selection, and care organisation.3 In North America there is 
even disagreement on the need to have a discrete, dedicated 
ward together with a dedicated stroke team.4,5
The Italian National Ministry of Health has promoted a 
stroke-unit research project (Research Project on Stroke 
services in Italy, PROSIT) since 2000, which involves 
many institutions around the country. This project enabled 
us to do a large-scale controlled prospective trial to assess 
the eﬀ ectiveness of stroke-unit care. Our aim was to 
determine whether all acute stroke patients admitted into 
stroke units have a better long-term outcome than those 
treated in conventional wards. 
Methods
Participants and procedures
This study is an observational controlled follow-up study 
on acute stroke patients, done in hospitals in Italy between 
2000 and 2004, to compare the long-term outcome of 
patients cared for in stroke units with those cared for in 
conventional wards. Seven Italian regions (Lombardia, 
Liguria, Veneto, Friuli-Venezia Giulia, Emilia-Romagna, 
Toscana, and Lazio), with a population of about 29 million 
and more than 50 000 acute stroke discharges every year, 
took part in the study.
The study was done in accordance with guidelines for 
good clinical practice and the declaration of Helsinki. 
Central and local ethical committee approval was sought. 
A patient information standard procedure supported 
the patient consent process to use clinical data for 
research purposes. Oral consent was obtained by phone 
at the time of the follow-up telephone call. 
We deﬁ ned the stroke unit as a hospital ward with 
dedicated beds (at least 80% stroke admission) and with 
a dedicated stroke staﬀ  (at least one physician and one 
nurse) who work exclusively in the care of stroke 
patients. The conventional ward was deﬁ ned as a 
hospital service with neither dedicated beds nor staﬀ , in 
which stroke patients are cared for together with other 
patients (eg, neurological, internal medicine, cardio-
logical). To identify stroke units and conventional 
wards, we audited the local hospital services of all 
regional hospital sites that had discharged at least 
50 acute stroke patients in the previous year. We also 
gathered data on the service characteristics (setting, 
organisation, and process of care). The audit process 
terminated in February, 2001, and 31 stroke units and 
393 conventional wards were identiﬁ ed. The details of 
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the data gathered during this phase of the study have 
been described previously.6,7
For ward characteristics, the major elements were 
dichotomised as follows: hospital setting (academic 
hospital, presence in the same hospital of intensive 
care, neurosurgery, vascular surgery, and rehabilitation 
depart ments), unit setting (all neurological beds, yearly 
unit admission more than 100 patients per year, 
continuous electrocardiography monitoring equipment 
more than two per ten beds), staﬃ  ng per unit ward 
(number of full-time physicians, nurses, and therapists: 
more than 2, 5, and 0·5 per ten patients, respectively), 
diagnostic investigation (availability over 24 h, 7 days a 
week, of cranial CT scan, brain MRI scan, 
echocardiography, duplex ultra sound, and cerebral 
catheter angiography), and process of care (declared 
use in the unit of written nurse care protocols, practice 
of multidisciplinary team meetings, and of early 
mobilisation). 
Acute stroke patients were identiﬁ ed by the Discharge 
Related Group (DRG) 14 code. DRG 14 corresponds to 
ICD-9-CM 431, 432, 433, 434, 436, and 437 codes that have 
been shown to be highly speciﬁ c for acute stroke.8 
Ischaemic and haemorrhagic strokes were accepted. The 
diagnosis and the duration of symptoms (less than 48 h) 
were conﬁ rmed by assessment of clinical records. We 
included all cases with acute stroke who were admitted 
during the last 9 months of 2001 in the 31 stroke units 
previously identiﬁ ed. Patients for whom clinical data were 
not available or those readmitted to the same service in 
1 year were excluded. Controls were a sample selected with 
a computer-generated random numbers list stratiﬁ ed by 
regions of about 20% of acute stroke cases admitted in 
each of the 393 conventional wards during the same 
period. To avoid selection and performance bias, we 
included the patients admitted after ﬁ nishing the auditing 
process described above. 
16 trained independent clinicians reviewed patients’ 
clinical records blinded to the patient’s hospital status. 
They conﬁ rmed diagnoses of acute stroke and recorded 
demographic, clinical, and in-hospital outcome data. The 
following baseline characteristics were recorded: age, male 
sex, admission time, intracranial haemorrhage at ﬁ rst CT 
scan, atrial ﬁ brillation at ﬁ rst electrocardiograph, systolic 
and diastolic arterial blood pressure, uncon sciousness 
(score less than 4 of eye opening on the Glasgow coma 
scale) and drift in at least one limb at motor assessment.  
Follow-up assessments were done between 2002 and 
2004 centrally for all regions. The assessors were an 
independent group of 21 medical students and four nurses 
trained to use a structured follow-up form, masked to the 
patient’s hospital status. They registered the patients’ vital 
status, place of residence, and functional ability with a 
modiﬁ ed Rankin scale. The modiﬁ ed Rankin scale graded 
the patients from grade 0 (no symptoms) to grade 5 
(bedridden, incontinent, and requiring constant nursing 
care and attention). The inter-observer agreement and its 
use by telephone are reliable.9,10 If the patient was unwilling 
to answer the questions, information was obtained from a 
carer or proxy. About a third of patients—38% of those 
receiving stroke-unit care and 32% of controls—completed 
the telephone interviews by themselves.
The primary outcome measure was death or dependency 
condition (ie, Rankin score higher than two) recorded at 
the time of long-term follow-up. Secondary outcomes were 
in-hospital case fatality, long-term mortality, and long-term 
living condition (ie, whether the patient was living at home 
or not) at follow-up. 
Statistical analysis
We aimed to recruit a sample of about 10 000 cases from 
about 200 hospitals, each admitting at least ten patients, 
which would have 80% power to detect an absolute risk 
diﬀ erence of 6% (two sided p=0·05) if 62% of those 
treated in a conventional ward were dead or had a poor 
outcome, to detect an absolute risk diﬀ erence of 3% if 
18% treated in conventional wards were dead at discharge, 
and to detect an absolute risk diﬀ erence of 3% if 29% 
treated in a conventional ward were not living at home at 
the long-term follow-up assessment. The sample size for 
hospital clusters was estimated assuming a coeﬃ  cient of 
variation of 0·22.11
Hospitals’ intra-cluster correlation coeﬃ  cients were 
calculated for all baseline variables.12 The outcome 
analyses take into account all included cases. Cases lost to 
follow-up were counted in the denominators. To 
determine whether their inclusion aﬀ ected the results, 
we did best-case and worst-case scenario analyses. The 
best-case scenario was analysed on the basis of the 
assumption that the patients who were lost to follow-up 
were alive and independent in the stroke-unit group and 
dead or disabled in the conventional ward group. We also 
31 stroke units in 30 hospitals* 393 conventional wards in
244 hospitals*
 332 unavailable data (6%)
 152 readmissions (3%)
 184 refused consent (3%)
 158 unavailable data (2%)
 85 readmissions (1%)
 213 refused consent (3%)
 5604 consecutive admissions
  in 2001 eligible
 4936 stroke-unit patients with
  data at baseline
 4764 stroke-unit patients 
  completed follow-up
 172 lost to follow-up  175 lost to follow-up
 7092 randomly sampled from 
  2001 admissions eligible
 6636 control patients with
  data at baseline
 6461 control patients
  completed follow-up
Figure 1: Trial proﬁ le
*14 hospitals had both stroke unit and conventional ward.
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did a worst-case scenario analysis on the basis of the 
assumption that the patients lost to follow-up in the stroke 
unit were dead or disabled and were alive and independent 
in the conventional ward group. 
Multivariate analyses were done to assess the association 
between type of unit care and patient out comes, adjusting 
for patient characteristics (age, sex, time from stroke onset, 
intracranial haemorrhage, atrial ﬁ brillation, level of 
consciousness). All multivariate logistic regression models 
for the main and subgroup analyses were done with 
generalised estimating equations to account for clustering 
of predictor variables and outcomes at diﬀ erent hospital 
levels. To determine goodness-of-ﬁ t, the ﬁ nal model was 
assessed by Hosmer-Lemeshow test with ten risk intervals. 
For time-to-event outcomes, we used Cox regression 
survival analyses; hazard ratios were clustered at hospital 
level. Statistical analyses were done with Stata version 8.0.
Role of the funding source
The Italian National Ministry of Health and Lombardia 
Regional Health Department funded the study. The 
sponsors had no role in study design, data collection, data 
analysis, data interpretation or writing the report. The 
corresponding author had full access to all the data, and 
had ﬁ nal responsibility to submit for publication.
Results
Figure 1 shows the trial proﬁ le. At baseline, data were 
available for 11 572 acute stroke patients from 424 units and 
260 hospitals were studied. 16 hospitals had only stroke 
units and 230 only conventional wards; 14 hospitals had 
both types of ward. The number of cases for the three types 
of hospitals were 2502, 6260, and 2810, respectively. Table 1 
shows the baseline characteristics for these patients. 90% 
of baseline data were complete. 
Table 2 presents data on the follow-up status of patients. 
95% of follow-up data were complete. 347 (3%) patients 
were not found at the telephone number provided during 
hospitalisation, and it was not possible to trace them by 
asking the local municipal administrative oﬃ  ce of declared 
residence. These individuals were thus lost to follow-up. 
These cases did not diﬀ er signiﬁ cantly from the included 
cases in terms of the characteristics of patients. The mean 
follow-up time was much the same for stroke units as it 
was control groups (19·7 [SD 6·9] months vs 20·4 [7·2] 
months). Overall, 1576 patients died in the hospital; 2169 
(19%) died during the follow-up period (table 2). 
Patients who received stroke-unit care were less likely to 
be dead or disabled than the controls by the end of follow-
up after adjusting for inter-hospital variability (OR 0·81, 
95% CI 0·72–0·91; p=0·0001; table 3). Inclusion of those 
lost to follow-up did not aﬀ ect our results; OR in the best-
case scenario was 0·70 (95% CI 0·61–0·79), whereas in the 
worst-case scenario it was 0·91 (0·82–0·99). Com parison 
of the outcomes of patients admitted to hospitals with 
stroke units, irrespective of whether they were admitted to 
stroke unit or normal ward, with those of patients admitted 
to hospitals without such units showed much the same 
association (0·81, 0·71–0·91; p=0·0001). 
The possible beneﬁ t of stroke-unit care was also evident 
for in-hospital, long-term mortality, and for the likelihood 
of not being at home 2 years after hospital discharge 
(table 3). Survival of patients treated in stroke units was 
Patients in stroke 
unit (n=4936)
Patients in 
control wards 
(n=6636)
Intra-class 
correlation 
coeﬃ  cient
Age (years) 72 (12·9) 76 (12·2) 0·038
Men 2590 (52%) 3195 (47%) 0·001
Admission within 6 h 1926 (39%) 2526 (36%) 0·168
Intracranial haemorrhage 412 (7%) 859 (13%) 0·214
Atrial ﬁ brillation 794 (16%) 1280 (19%) 0·034
Systolic blood pressure (mm Hg) 159 (28·9) 164 (37·4) 0·022
Diastolic blood pressure (mm Hg) 87 (14·4) 90 (14·4) 0·043
Unconsciousness 675 (13%) 1303 (20%) 0·034
Unconsciousness or motor impairment 3297 (70%) 4576 (69%) 0·066
Aphasia 1307 (25%) 1819 (26%) 0·042
Length of stay in hospital (days) 12 (11·3) 12 (12·2) 0·070
*Adjusted for hospital clusters. Data are mean (SD) or number (%).
Table 1: Distribution of baseline characteristics 
Stroke unit (n=4936) Control (n=6636)
Follow-up (months) 19·7 (6·9) 20·4 (7·2)
Lost to follow-up 172 (3%) 175 (3%)
In-hospital case fatality 542 (11%) 1034 (16%)
Death after discharge 821 (17%) 1348 (20%)
Alive at follow-up 3401 (69%) 4079 (61%)
Rankin score=0* 735 (22%) 804 (20%)
Rankin score=1* 871 (26%) 941 (23%)
Rankin score=2* 547 (16%) 604 (15%)
Rankin score=3* 590 (17%) 740 (18%)
Rankin score=4* 471 (14%) 713 (17%)
Rankin score=5* 187 (5%) 277 (7%)
Stroke recurrence 195 (4%) 265 (4%)
Rehabilitation programme 1089 (22%) 1381 (21%)
New hospital admissions 835 (17%) 992 (15%)
Data are mean (SD) or number (%).*Data are number (percentage of those alive at 
follow-up).
Table 2: Status of patients 2 years after admission to hospital
Stroke unit 
(n=4936)
Control 
(n=6636)
Odds ratio 
(95% CI)*
p value
In-hospital case fatality 542 (11%) 1034 (15%) 0·78 (0·64–0·95) 0·016
Long-term mortality 1363 (28%) 2382 (36%) 0·79 (0·68–0·91) 0·001
Death or disability 2611 (53%) 4112 (62%) 0·81 (0·72–0·91) 0·0001
Not living at home 1743 (35%) 2829 (3%) 0·85 (0·74–0·97) 0·019
*Adjusted by age, sex, time from stroke onset, intracranial haemorrhages, atrial ﬁ brillation, and unconsciousness, and 
clustered at the hospital level. 
Table 3: Associations between type of service
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signiﬁ cantly higher than of controls (hazard ratio 0·86, 
0·77–0·97; p=0·0001; ﬁ gure 2). The diﬀ erence in survival 
between the two groups was most pronounced during 
the ﬁ rst month after admission (ﬁ gure 2). 
Stroke-unit care was associated with a reduction in the 
likelihood of death or disability for all subgroups of 
patients. There were no signiﬁ cant interactions between 
patient characteristics and the eﬀ ect of stroke-unit care, 
with the exception of patients with intracranial 
haemorrhage, who did better if cared for in a stroke-unit 
ward (ﬁ gure 3). 
None of the 19 elements of setting, organisation, and 
processes of care in stroke units changed the probability 
of the patient being dead or disabled by the end of follow-
up, except for MRI scan availability 24 h a day, 7 days a 
week. Patients admitted to a conventional ward had a 
better outcome if the ward beds were neurological and 
belonged to an academic hospital (ﬁ gure 4). 
Discussion
This observational follow-up study, done in the clinical 
environment in Italy on a large sample of patients with 
acute stroke, shows that there is an association between 
stroke-unit care provided in the acute phase of the disease 
and improvement of stroke outcome. In this setting, 
stroke-unit care could reduce in-hospital case fatality and 
also increase the proportion of patients living independently 
about 2 years after discharge. The possible beneﬁ t is 
maintained over time and is evident both for patients aged 
less than 75 years and for those over 75 years. 
Our results are in agreement with those of a meta-
analysis of 23 randomised controlled trials on about 
5000 participants.1 We also provide evidence that acute 
stroke-unit care (ie, admitting patients within 48 h of 
stroke onset) could improve the patients’ outcome. Other 
evidence for this eﬀ ect is scarce, despite the fact that most 
new stroke units had been organised for the care of very 
acute patients. In fact, 13 systematic reviews of this area of 
research included participants within 7 days of stroke 
onset, nine included patients after 7 days, and only one 
trial enrolled patients within 24 h of stroke. This small 
trial was unable alone to show any beneﬁ t for stroke-unit 
care (OR 0·94, 95% CI 0·67–1·33).13
The design of our study did not allow a random, 
concealed assignment of patients to the two treatment 
modalities, and the apparent beneﬁ ts for stroke-unit care 
could be due to selection bias and incomplete adjustment 
for patient characteristics. However, our ﬁ ndings are lent 
support by several factors. First, the directors and staﬀ  of 
the stroke units and conventional wards studied here were 
unaware of the ongoing trial when they admitted and 
treated the enrolled patients, which should reduce 
selection and performance bias. Second, all major known 
outcome predictors that had an unbalanced distribution 
between the two treatment groups were included in the 
logistic regression analysis. The analysis model had a high 
goodness-of-ﬁ t, and the inclusion of other, less relevant 
  
 n N n N 95% CI 
Overall 2611 4936 4112 6636
Age
Under 75 years 855 2513 1097 2758
Over 75 years 1756 2423 3033 3878
OR (95%) interaction
1·05 (0·89–1·25)
Sex
Women  1390 2346 2358 3441
Men 1221 2590 1754 3195
OR (95%) interaction 
0·98 (0·82–1·16)
Time of admission
Within 6 h 1113 1926 1631 2526
After 6 h 1498 3009 2481 4110
OR (95%) interaction
0·91 (0·76–1·09)
Intracranial haemorrhage
Yes 157 412 575 859
No 2454 4524 3537 5777
OR (95%) interaction
1·56 (1·16–2·10)
Atrial ﬁbrillation
Yes 562 794 976 1280
No 2049 4142 3136 5356
OR (95%) interaction
0·98 (0·77–1·24)
Consciousness
Unconscious 601 675 1191 1303
Conscious 2010 4261 2921 5333
OR (95%) interaction
0·89 (0·64–1·24)
Stroke unit Conventional ward Odds ratio
0·5 1 1·5
Favours 
stroke unit
Favours 
conventional ward
Figure 3: Eﬀ ect of stroke unit care on death or disability by patient subgroups 
Data adjusted for patient characteristics and clustered at the hospital level. 
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Figure 2: Survival curves for patients admitted to stroke unit or conventional ward 
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predictors would not have modiﬁ ed the ﬁ nal analysis 
result substantially (Hosmer-Lemeshow χ2 4·90; df 10; 
p>0·7678). Third, the analysis that compared outcomes of 
patients admitted to hospitals with stroke units to those 
admitted to hospitals without stroke units conﬁ rmed the 
beneﬁ t of treatment in a stroke unit. Such intra-hospital 
analysis should restrict the error due to in-hospital 
selection bias. Some uncertainty of the validity of our 
results still remains due to the non-randomised nature of 
this study. However, to do a randomised trial would be 
impossible for ethical reasons. Moreover, assessment of 
outcome in our study was prospective and masked, and 
less than 3% of patients were lost to follow-up. Additionally, 
the analysis was clustered at the hospital level to account 
for service variability. Furthermore, the inclusion of a large 
sample of stroke patients means that our ﬁ ndings should 
have a good level of generalisability. 
Other non-randomised prospective studies that aimed 
to assess the eﬀ ect of stroke-unit care have produced 
conﬂ icting results. The Swedish Riks-Stroke studies14,15 
suggest that stroke-unit care is favourable only for less 
severe patients, whereas the UK national stroke audit16 
showed that stroke-unit care substantially reduced in-
hospital case fatality, and the US Brain Attack Coalition 
study17 did not show any short-term beneﬁ t of treatment in 
a stroke unit. Diﬀ erences in study design could explain, in 
part, the diﬀ ering results. Both the UK and US studies 
considered short-term outcomes; the eﬀ ects of stroke-unit 
care seem to be more apparent after long-term follow-up, 
as we have shown here.1,18 However, higher standards of 
care for stroke in the conventional-ward groups in previous 
studies could have reduced their ability to identify 
diﬀ erences in outcomes compared with stroke units. In 
fact, more than 70% of hospitals included in these three 
studies had an organised stroke unit.15–17 The presence of a 
stroke unit probably provides a general stimulus for stroke 
management, inﬂ uencing the quality of stroke care even 
in wards with no formal stroke-unit organisation. By 
contrast, only 12% of hospitals in the seven Italian regions 
studied here provided stroke-unit care. 
To be able to accurately predict which patients will gain 
most from stroke-unit care could be important, not just 
because of restricted resources, but also to aid individual 
patients to get the most appropriate access. Some 
policymakers suggest the use of pragmatically restricted 
admission policies. However, this study, in accordance 
with other evidence, lends support to the view that there 
is no ﬁ rm evidence for restricting access according to 
patient characteristics—ie, age, sex, blood pressure, etc.1,19 
Previous reports,1,14 together with our results, indicate 
restricted use of stroke-unit care for patients with mild 
stroke. However, a larger sample of unconscious patients 
would be necessary to conﬁ rm this ﬁ nding. 
We aimed to identify the key components of an eﬀ ective 
acute stroke service. In view of the emergent evidence 
that a stroke unit with a minimum of dedicated beds and 
a dedicated staﬀ  is eﬀ ective, a key goal was to determine 
exactly what other components of those services could be 
crucial for achieving better outcomes. That we showed 
that none of the major stroke-unit elements of care was 
independently associated with a better outcome is 
unsurprising. However, caution is needed when 
interpreting subgroup analyses, especially since only a 
small number of outcome events were observed, which 
restricted the statistical power. Nonetheless, our ﬁ ndings 
are in line with those of the Brain Attack Coalition study,17 
which used a similar multifactorial analysis, and in part 
with those of the SCOPES study,20 which recorded only a 
slight association between the probability of being 
discharged and complete adherence to 15 process-of-care 
rules. Other studies considered either only the association 
between elements of care with a stroke unit15,21–23 or the 
eﬀ ect on outcome of separate elements such as presence 
of a continuous monitoring system24,25 or the practice of 
early rehabilitation.26 The eﬀ ectiveness of a single element 
of care could be determined only by doing a large 
randomised controlled trial in which the other elements 
do not change during the experiment, which would be 
very diﬃ  cult. Nevertheless, the overall eﬀ ectiveness of 
stroke-unit care could also be attributed to non-measurable 
factors—eg, the enthusiasm, motivation, and 
specialisation of staﬀ —which cannot be attributed to a 
single individual element separately. 
Hospital setting
Intensive unit 0·99 (0·65–1·52)
Neurosurgery department 1·27 (0·84–1·89)
Rehabilitation department 1·18 (0·84–1·89)
Vascular surgery department 1·05 (0·79–1·37)
Academic hospital 1·23 (0·95–1·59)
Unit setting
Neurological beds 0·88 (0·55–1·39)
More than 100 patients/year 1·14 (0·75–1·72)
More than two monitors/bed 1·01  (0·78–1·33)
Staﬃng
More than 2 physicians/10 pts 0·76 (0·47–1·22)
More than 5 nurses/10 pts 1·01 (0·73–1·41)
More than  0·5 therapists/10 pts 1·01 (0·76–1·33)
Process of care
Nurses protocols 0·82 (0·51–1·32)
Early mobilisation 0·89 (0·51–1·32)
Multidisciplinary meetings 0·97 (0·75–1·25)
Diagnostic exams available 24/7
CT scan 1·54 (0·66–3·57)
MRI scan 0·69 (0·51–0·89)
Ultrasonography 1·35 (0·96–1·89)
Echocardiography 0·81 (0·60–1·11)
Digital angiography 0·76 (0·49–1·16)
 
 1·18 (0·94–1·41)
 0·99 (0·83–1·19)
 0·97 (0·85–1·10)
 1·18 (1·02–1·37)
 0·72 (0·58–0·90)
 0·64 (0·55–0·75)
 0·91 (0·79–1·04)
 0·86 (0·54–1·37)
 0·93 (0·81–1·08)
 1·02 (0·89–1·5)
 1·06 (0·91–1·25)
 0·93 (0·83–1·06)
 0·93 (0·82–1·05)
 0·99 (0·88–1·12)
 0·81 (0·62–1·06)
 0·94 (0·82–1·09)
 0·93 (0·81–1·06)
 0·98 (0·86–1·11)
 0·96 (0·83–1·11)
Stroke unit
Odds ratio (95% CI)
Control
Odds ratio (95% CI)
0·5 1 1·5 0·5 1 1·5
Favour service characteristics
Figure 4: Eﬀ ect of service characteristics on death or disability 
Stroke unit and control services were analysed separately. Data adjusted for patient and unit characteristics and 
clustered at the hospital level. 
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In conclusion, this study, which used a broad but 
reliable deﬁ nition of stroke-unit models on the basis of 
the use of beds and staﬀ  dedicated exclusively to stroke 
patients, indicates that, provided admission occurs within 
48 h of onset, patients with acute stroke should be treated 
in stroke-unit wards with dedicated beds and staﬀ , 
irrespective of age. At present, there is no indication that 
any further element of care is of beneﬁ t. This simple 
organisation of services is easy to implement, with great 
beneﬁ t in terms of reduced mortality and disability. 
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